Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Ann Surg Oncol. 2019 Jun 27;26(9):2821–2830. doi: 10.1245/s10434-019-07508-3

Table 1:

Demographic and pathologic data of patients with high and low degrees of CTL-TC mixing.

Characteristic High AUC n=46 Low AUC n=131 p-value
Mean age, yrs 56.8 61.9 0.0157

Gender
 Male 33 (72%) 66 (50%) 0.0154
 Female 13 (28%) 65 (50%)

Resection
 Wedge or segment 21 (46%) 56 (43%) 0.8854
 Lobectomy 16 (20%) 45 (34%)
 Trisectionectomy 9 (34%) 30 (23%)

Extra-hepatic disease
 Yes 5 (11%) 17 (13%) 0.2019
 No 41 (89%) 114 (87%)

Prior liver resection
 Yes 3 (7%) 9 (7%) 1.000
 No 43 (94%) 122 (93%)

Preoperative chemotherapy
 Yes 33 (79%) 82 (63%) 0.2867
 No 13 (21%) 49 (37%)

Mean preop CEA (95% CI) 134.9 (−146–416) 127.6 (−19–274) 0.9629

Mean largest tumor diameter, cm (95% CI) 4.3 (4.2–5.3) 4.8 (3.4–5.2) 0.4201

Tumor number
  1 28 (60%) 65 (50%) 0.2276
  2 5 (11%) 29 (22%)
  3 5 (11%) 19 (15%)
  4 3 (7%) 8 (6%)
  5 0 (0%) 3 (2%)
   >5 5(11%) 7 (5%)

Disease free interval, mos (95% CI) 16.0 (10.8–21.1) 18.4 (15.4–21.5) 0.4188

Clinical risk score
  1 20 (43%) 42 (32%) 0.9033
  2 16 (35%) 54 (41%)
  3 7 (15%) 20 (15%)
  4 3 (7%) 14 (11%)
  5 0 (0%) 1 (1%)